Cefoperazone pharmacokinetics in acute childhood meningitis. (Q54486536)

30 May 2018

title

Cefoperazone pharmacokinetics in acute childhood meningitis. (English)

1 reference

30 May 2018

1 reference

1 reference

Chartrand SA

1

1 reference

30 May 2018

Marks MI

2

1 reference

30 May 2018

Johnston JT

3

1 reference

30 May 2018

Frederick DF

4

1 reference

30 May 2018

Scribner RK

5

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 December 1983

1 reference

30 May 2018

The Journal of Pediatrics

published in

1 reference

30 May 2018

volume

103

1 reference

30 May 2018

issue

6

1 reference

30 May 2018

page(s)

991-995

1 reference

30 May 2018

Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Factors affecting the analysis of cefoperazone in cerebral spinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Pharmacokinetics of cefoperazone in full-term and premature neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980738-0

10.1016/S0022-3476(83)80738-0

7 January 2021

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018